Browse by Person

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | No Grouping
Jump to: Article | Monograph
Number of items: 19.


Vasudev, NS, Wilson, M, Stewart, GD et al. (13 more authors) (2020) Challenges of early renal cancer detection: symptom patterns and incidental diagnosis rate in a multicentre prospective UK cohort of patients presenting with suspected renal cancer. BMJ Open, 10 (5). e035938. ISSN 2044-6055

Hornigold, N, Dunn, KR, Craven, RA et al. (22 more authors) (2020) Dysregulation at multiple points of the kynurenine pathway is a ubiquitous feature of renal cancer: implications for tumour immune evasion. British Journal of Cancer. ISSN 0007-0920

Cheeseman, S, Thompson, M, Sopwith, W et al. (18 more authors) (2020) Current Treatment and Outcomes Benchmark for Locally Advanced or Metastatic Urothelial Cancer From a Large UK-Based Single Centre. Frontiers in Oncology, 10. 167.

Vasudev, NS, Hutchinson, M, Trainor, S et al. (17 more authors) (2020) UK Multicenter Prospective Evaluation of the Leibovich Score in Localized Renal Cell Carcinoma: Performance has Altered Over Time. Urology, 136. pp. 162-168. ISSN 0090-4295

Buckley, HL, Collinson, FJ, Ainsworth, G et al. (15 more authors) (2019) PRISM protocol: A randomised phase II trial of nivolumab in combination with alternatively scheduled ipilimumab in first-line treatment of patients with advanced or metastatic renal cell carcinoma. BMC Cancer, 19. ARTN: 1102. ISSN 1471-2407

Collinson, F, Brown, S, Buckley, H et al. (11 more authors) (2018) PRISM: A randomised phase II trial of nivolumab in combination with alternatively scheduled ipilimumab in first-line treatment of patients with advanced or metastatic renal cell carcinoma. Annals of Oncology (Part of special issue:Abstract Book of the 43rd ESMO Congress (ESMO 2018) 19–23 October 2018, Munich, Germany), 29 (8). viii331-viii331. ISSN 0923-7534

Cheung, SY, Henrot, M, Al-Saad, M et al. (17 more authors) (2018) TRPC4/TRPC5 channels mediate adverse reaction to the cancer cell cytotoxic agent (-)-Englerin A. Oncotarget, 9 (51). pp. 29634-29643. ISSN 1949-2553

Karimzadeh, M, Jandaghi, P, Papadakis, AI et al. (11 more authors) (2018) Aberration hubs in protein interaction networks highlight actionable targets in cancer. Oncotarget, 9 (38). pp. 25166-25180. ISSN 1949-2553

Robinson, SP, Boult, JKR, Vasudev, NS et al. (1 more author) (2017) Monitoring the vascular response and resistance to sunitinib in renal cell carcinoma in vivo with susceptibility contrast MRI. Cancer Research, 77 (15). pp. 4127-4134. ISSN 0008-5472

Arseneault, M, Monlong, J, Vasudev, NS et al. (25 more authors) (2017) Loss of chromosome Y leads to down regulation of KDM5D and KDM6C epigenetic modifiers in clear cell renal cell carcinoma. Scientific Reports, 7. 44876. ISSN 2045-2322

Bridgeman, VL, Vermeulen, PB, Foo, S et al. (19 more authors) (2017) Vessel co-option is common in human lung metastases and mediates resistance to anti-angiogenic therapy in preclinical lung metastasis models. The Journal of Pathology, 241 (3). pp. 362-374. ISSN 0022-3417

Ludlow, MJ, Gaunt, HJ, Rubaiy, HN et al. (5 more authors) (2017) (-)-Englerin A-evoked Cytotoxicity is Mediated by Na+ Influx and Counteracted by Na+/K+-ATPase. Journal of Biological Chemistry, 292 (2). pp. 723-731. ISSN 0021-9258

Gaunt, HJ, Vasudev, NS and Beech, DJ (2016) Transient receptor potential canonical 4 and 5 proteins as targets in cancer therapeutics. European Biophysics Journal, 45 (7). pp. 611-620. ISSN 0175-7571

Scelo, G, Hofman, JN, Banks, RE et al. (26 more authors) (2016) International cancer seminars: a focus on kidney cancer. Annals of Oncology, 27 (8). pp. 1365-1366. ISSN 0923-7534

Hayward, JS, Makinde, O and Vasudev, NS (2016) Letters of condolence: assessing attitudes and variability in practice amongst oncologists and palliative care doctors in Yorkshire. ecancermedicalscience, 10. 642. ISSN 1754-6605

Bridgeman, VL, Wan, E, Foo, S et al. (12 more authors) (2016) Preclinical Evidence That Trametinib Enhances the Response to Antiangiogenic Tyrosine Kinase Inhibitors in Renal Cell Carcinoma. Molecular Cancer Therapeutics, 15 (1). pp. 172-183. ISSN 1535-7163

Akbulut, Y, Gaunt, HJ, Muraki, K et al. (12 more authors) (2015) (−)-Englerin A is a Potent and Selective Activator of TRPC4 and TRPC5 Calcium Channels. Angewandte Chemie International Edition, 54 (12). pp. 3787-3791. ISSN 1433-7851

Vasudev, NS and Reynolds, AR (2014) Anti-angiogenic therapy for cancer: Current progress, unresolved questions and future directions. Angiogenesis, 17 (3). pp. 471-494. ISSN 0969-6970


Selby, PJ, Banks, RE, Gregory, W et al. (50 more authors) (2018) Methods for the evaluation of biomarkers in patients with kidney and liver diseases: multicentre research programme including ELUCIDATE RCT. Report. NIHR Journals Library , Southampton, Uk. ISSN 2050-4322

This list was generated on Sun Aug 9 00:03:19 2020 BST.